Projects per year
Fingerprint
Dive into the research topics where James C.M. Brust is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mentoring of multidisciplinary global health research in tuberculosis and HIV
Brust, J. C. M. & Brust, J. C. M.
National Institute of Allergy and Infectious Diseases
7/2/20 → 6/30/22
Project: Research project
-
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting
12/26/19 → 11/30/24
Project: Research project
-
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
2/5/15 → 1/31/21
Project: Research project
-
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
Brust, J. C. M. & Brust, J. C. M.
National Institute of Allergy and Infectious Diseases
2/5/15 → 1/31/21
Project: Research project
-
Linezolid toxicity in patients with drug-resistant tuberculosis: A prospective cohort study
Wasserman, S., Brust, J. C. M., Abdelwahab, M. T., Little, F., Denti, P., Wiesner, L., Gandhi, N. R., Meintjes, G. & Maartens, G., Apr 1 2022, In: Journal of Antimicrobial Chemotherapy. 77, 4, p. 1146-1154 9 p.Research output: Contribution to journal › Article › peer-review
-
Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment
Koele, S. E., Van Beek, S. W., Maartens, G., Brust, J. C. M. & Svensson, E. M., Mar 2022, In: Antimicrobial agents and chemotherapy. 66, 3, e01749-21.Research output: Contribution to journal › Article › peer-review
-
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
Brust, J. C. M., Gandhi, N. R., Wasserman, S., Maartens, G., Omar, S. V., Ismail, N. A., Campbell, A., Joseph, L., Hahn, A., Allana, S., Hernandez-Romieu, A. C., Zhang, C., Mlisana, K., Viljoen, C. A., Zalta, B., Ebrahim, I., Franczek, M., Master, I., Ramangoaela, L., Te Riele, J. & 1 others, , Dec 1 2021, In: Clinical Infectious Diseases. 73, 11, p. 2083-2092 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Evidence-based definition for extensively drug-resistant tuberculosis
Roelens, M., Migliori, G. B., Rozanova, L., Estill, J., Campbell, J. R., Cegielski, J. P., Tiberi, S., Palmero, D., Fox, G. J., Guglielmetti, L., Sotgiu, G., Brust, J. C. M., Bang, D., Lienhardt, C., Lange, C., Menzies, D., Keiser, O. & Raviglione, M., Sep 15 2021, In: American journal of respiratory and critical care medicine. 204, 6, p. 713-722 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Linezolid population pharmacokinetics in south african adults with drug-resistant tuberculosis
Abdelwahab, M. T., Wasserman, S., Brust, J. C. M., Dheda, K., Wiesner, L., Gandhi, N. R., Warren, R. M., Sirgel, F. A., Meintjes, G., Maartens, G. & Denti, P., Dec 2021, In: Antimicrobial agents and chemotherapy. 65, 12, e01381-21.Research output: Contribution to journal › Article › peer-review
2 Scopus citations